HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takashi Nakahara Selected Research

Ammonia

8/2019Percutaneous transvenous shunt occlusion for portosystemic encephalopathy due to lenvatinib administration to a patient with hepatocellular carcinoma and portosystemic shunt.
1/2019Early changes in ammonia levels and liver function in patients with advanced hepatocellular carcinoma treated by lenvatinib therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takashi Nakahara Research Topics

Disease

46Hepatocellular Carcinoma (Hepatoma)
06/2022 - 01/2012
22Fibrosis (Cirrhosis)
07/2022 - 07/2013
18Infections
02/2022 - 11/2013
18Neoplasms (Cancer)
08/2021 - 08/2012
16Chronic Hepatitis C
01/2021 - 12/2014
15Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 06/2015
10Non-alcoholic Fatty Liver Disease
01/2022 - 02/2014
7Liver Diseases (Liver Disease)
03/2022 - 02/2014
7Chronic Hepatitis B
01/2021 - 01/2016
6Hepatic Encephalopathy
11/2020 - 07/2013
5Neoplasm Metastasis (Metastasis)
10/2021 - 10/2018
5Thrombosis (Thrombus)
04/2021 - 06/2015
5Inflammation (Inflammations)
06/2020 - 04/2010
5Disease Progression
04/2020 - 04/2011
4Hepatitis B
01/2021 - 03/2017
3Sarcopenia
02/2020 - 10/2018
3Dyslipidemias (Dyslipidemia)
08/2019 - 11/2012
3Hemorrhage
01/2018 - 11/2015
2Insulin Resistance
03/2022 - 02/2014
2Alcoholic Fatty Liver
07/2021 - 11/2012
2Wounds and Injuries (Trauma)
01/2021 - 11/2015
2Hepatitis
01/2021 - 12/2018
2Type 2 Diabetes Mellitus (MODY)
01/2021 - 01/2018
2Necrosis
01/2021 - 01/2018
2Microsatellite Instability
10/2020 - 07/2020
2Hepatitis C
09/2020 - 12/2014
2Edema (Dropsy)
02/2020 - 08/2016
2Chronic Hepatitis (Chronic Active Hepatitis)
01/2020 - 12/2018
2Lymphatic Metastasis
08/2019 - 08/2012
2Anemia
06/2017 - 11/2016
2Critical Illness (Critically Ill)
06/2010 - 01/2009
2Heat Stroke (Heatstroke)
04/2010 - 01/2009
1Fatty Liver
07/2022
1Hypoglycemia (Reactive Hypoglycemia)
03/2022
1Hyperglycemia
03/2022

Drug/Important Bio-Agent (IBA)

16lenvatinibIBA
04/2022 - 01/2019
13Antiviral Agents (Antivirals)IBA
02/2022 - 08/2016
13InterferonsIBA
11/2020 - 07/2013
12Sorafenib (BAY 43-9006)FDA Link
01/2021 - 01/2012
8Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2018
8Ribavirin (Virazole)FDA LinkGeneric
01/2020 - 12/2014
6AntigensIBA
01/2021 - 11/2016
6daclatasvirIBA
01/2020 - 08/2016
6asunaprevirIBA
01/2020 - 08/2016
5Hemoglobins (Hemoglobin)IBA
03/2022 - 05/2009
5Glucose (Dextrose)FDA LinkGeneric
03/2022 - 11/2014
5Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2021 - 12/2017
5DNA (Deoxyribonucleic Acid)IBA
01/2021 - 05/2014
5Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2021 - 03/2017
5Proteins (Proteins, Gene)FDA Link
11/2020 - 12/2009
5SofosbuvirIBA
11/2020 - 06/2017
5CytokinesIBA
01/2020 - 01/2009
4Pharmaceutical PreparationsIBA
01/2022 - 08/2019
4Alanine Transaminase (SGPT)IBA
01/2021 - 03/2014
4regorafenibIBA
01/2021 - 09/2018
3Cisplatin (Platino)FDA LinkGeneric
06/2022 - 08/2012
3Bevacizumab (Avastin)FDA Link
04/2022 - 08/2021
3atezolizumabIBA
04/2022 - 08/2021
3Blood Glucose (Blood Sugar)IBA
03/2022 - 01/2017
3EnzymesIBA
02/2021 - 10/2019
3Immunoglobulins (Immunoglobulin)IBA
01/2021 - 11/2016
3Tyrosine Kinase InhibitorsIBA
01/2021 - 01/2020
3Fetal Proteins (Fetoprotein)IBA
11/2020 - 01/2012
3NucleosidesIBA
01/2019 - 01/2018
3NucleotidesIBA
01/2019 - 01/2018
3HMGB1 Protein (HMG1)IBA
01/2018 - 12/2009
2Carrier Proteins (Binding Protein)IBA
01/2022 - 09/2020
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022 - 11/2012
2Immune Checkpoint InhibitorsIBA
02/2021 - 10/2020
2glecaprevir and pibrentasvirIBA
01/2021 - 01/2020
2Prothrombin (Factor II)IBA
01/2021 - 12/2017
2pembrolizumabIBA
10/2020 - 07/2020
2nasIBA
08/2020 - 06/2020
2Adrenal Cortex Hormones (Corticosteroids)IBA
07/2020 - 01/2009
2pibrentasvirIBA
04/2020 - 03/2019
2glecaprevirIBA
04/2020 - 03/2019
2RNA (Ribonucleic Acid)IBA
01/2020 - 04/2018
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2020 - 05/2016
2BilirubinIBA
10/2019 - 12/2017
2AmmoniaIBA
08/2019 - 01/2019
2ChemokinesIBA
07/2019 - 01/2018
2ledipasvirIBA
12/2018 - 11/2017
2Interleukin-8 (Interleukin 8)IBA
12/2018 - 12/2009
2entecavirFDA Link
12/2018 - 01/2018
2sofosbuvir drug combination ledipasvirIBA
04/2018 - 11/2017
2danaparoid (Orgaran)FDA Link
01/2018 - 06/2015
2Oxygen (Dioxygen)IBA
01/2018 - 04/2016
2telaprevirIBA
12/2014 - 12/2014
2Superoxides (Superoxide)IBA
11/2010 - 04/2010
1Capsules (Microcapsules)IBA
07/2022

Therapy/Procedure

43Therapeutics
06/2022 - 11/2010
12Drug Therapy (Chemotherapy)
06/2022 - 08/2012
7Radiotherapy
04/2021 - 08/2012
4Liver Transplantation
01/2021 - 03/2017
3Surgical Portasystemic Shunt (Portosystemic Shunt)
08/2019 - 07/2013
3Resuscitation
10/2016 - 01/2015
2Bariatric Surgery
01/2022 - 07/2021
2Hepatectomy
08/2019 - 08/2012
2Artificial Respiration (Mechanical Ventilation)
11/2010 - 06/2010
1Glycemic Control
03/2022